We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Bifeprunox in the Treatment of Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00193713
Recruitment Status : Completed
First Posted : September 19, 2005
Last Update Posted : January 16, 2015
Information provided by:
Solvay Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2006
  Study Completion Date : November 2006